0 NASDAQ Companies - October 6, 2020Solar Senior Capital Ltd. Announces Monthly Distribution of $0.10 Per Share for October 2020NEW YORK, Oct. 06, 2020 (GLOBE NEWSWIRE) — Solar Senior Capital Ltd. (the “Company”) (NASDAQ: SUNS) declared a distribution of […]Read More
0 NASDAQ Companies - October 6, 2020Gentherm Announces Date for 2020 Third Quarter Results News Release and Conference CallNORTHVILLE, Mich., Oct. 06, 2020 (GLOBE NEWSWIRE) — Gentherm (NASDAQ:THRM), a global market leader and developer of innovative thermal management […]Read More
0 NASDAQ Companies - October 6, 2020Cerence Reinvigorates Cerence Swype Keyboard for Automotive ApplicationsBURLINGTON, Mass., Oct. 06, 2020 (GLOBE NEWSWIRE) — Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, today announced […]Read More
0 NASDAQ Companies - October 6, 2020Conformis Reports Preliminary Third Quarter Revenue ResultsBILLERICA, Mass., Oct. 06, 2020 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS) today announced preliminary, unaudited, revenue results for the third […]Read More
0 NASDAQ Companies - October 6, 2020Kaleido Biosciences Provides Update on KB109 Clinical Data TimelineLEXINGTON, Mass., Oct. 06, 2020 (GLOBE NEWSWIRE) — Kaleido Biosciences, Inc. (Nasdaq: KLDO), today announced an update to its ongoing […]Read More
0 NASDAQ Companies - October 6, 2020Ocugen Engages Kemwell Biopharma for cGMP Manufacture of OCU200MALVERN, Pa., Oct. 06, 2020 (GLOBE NEWSWIRE) — Ocugen, Inc., (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and […]Read More
0 NASDAQ Companies - October 6, 2020FuelCell Energy Disputes Misleading Claims of Short SellerDANBURY, Conn., Oct. 06, 2020 (GLOBE NEWSWIRE) — FuelCell Energy, Inc. (Nasdaq: FCEL) (“FuelCell Energy” or the “Company”) yesterday became […]Read More
0 NASDAQ Companies - October 6, 2020Nephros Announces Preliminary Third Quarter Revenues of $2.1 MillionSOUTH ORANGE, NJ, Oct. 06, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that […]Read More
0 NASDAQ Companies - October 6, 2020Corbus Pharmaceuticals Announces Phase 2b Study of Lenabasum for Treatment of Cystic Fibrosis Did Not Meet Primary EndpointStudy did not meet primary endpoint of reducing rate of pulmonary exacerbationsLenabasum treatment had a favorable safety profile and was […]Read More
0 NASDAQ Companies - October 6, 2020Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its Third Quarter Ended September 30, 2020 Financial ResultsLOS ANGELES, Oct. 06, 2020 (GLOBE NEWSWIRE) — Crescent Capital BDC, Inc. (“Crescent BDC”) (NASDAQ: CCAP) today announced it will […]Read More